Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000950135-01-503764
Filing Date
2001-12-05
Accepted
2001-12-05 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b41185a1s-3a.txt S-3/A 139323
  Complete submission text file 0000950135-01-503764.txt   140754
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-74002 | Film No.: 1806304
SIC: 2836 Biological Products, (No Diagnostic Substances)